Your browser doesn't support javascript.
loading
Functional Immunostimulating DNA Materials: The Rising Stars for Cancer Immunotherapy.
Dai, Ziwen; Wang, Lei; Wang, Zhigang.
Afiliación
  • Dai Z; College of Materials Science and Engineering, Shenzhen University, Shenzhen, 518055, China.
  • Wang L; Key Laboratory of Optoelectronic Devices and Systems of Ministry of Education and Guangdong Province, College of Optoelectronic Engineering, Shenzhen University, Shenzhen, 518060, China.
  • Wang Z; College of Materials Science and Engineering, Shenzhen University, Shenzhen, 518055, China.
Macromol Biosci ; 21(6): e2100083, 2021 06.
Article en En | MEDLINE | ID: mdl-33896107
Cancer immunotherapy has risen as a promising method in clinical practice for cancer treatment and DNA-based immune intervention materials, along with DNA nanotechnology, have obtained increasing importance in this field. In this review, various immunostimulating DNA materials are introduced and the mechanisms via which they exerted an immune effect are explained. Then, representative examples in which DNA is used as the leading component for anticancer applications through immune stimulation are provided and their efficacy is evaluated. Finally, the challenges for those materials in clinical applications are discussed and suggestions for possible further research directions are also put forward.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptor Toll-Like 9 / Aptámeros de Nucleótidos / Antígeno B7-H1 / Receptor de Muerte Celular Programada 1 / Inhibidores de Puntos de Control Inmunológico / Inmunoterapia / Neoplasias Límite: Humans Idioma: En Revista: Macromol Biosci Asunto de la revista: BIOQUIMICA Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptor Toll-Like 9 / Aptámeros de Nucleótidos / Antígeno B7-H1 / Receptor de Muerte Celular Programada 1 / Inhibidores de Puntos de Control Inmunológico / Inmunoterapia / Neoplasias Límite: Humans Idioma: En Revista: Macromol Biosci Asunto de la revista: BIOQUIMICA Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Alemania